Company · CIK 0000899923 · SIC 2835 — In Vitro & In Vivo Diagnostic Substances · Nasdaq
MYRIAD GENETICS INC · MYGN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 FForm 4 → | Sep 22, 4:12 pm EDT | Benjamin Richard WheelerChief Financial Officer | 2,555 | $4.01 | $10,246 | 287,193 | — | |
| Sep 16, 2026 AForm 4 → | Sep 17, 4:34 pm EDT | Vishal SikriEVP, Commercial | 257,731 | — | — | 351,224 | — | |
| Sep 3, 2026 FForm 4 → | Sep 8, 4:18 pm EDT | Jennifer Lynne FoxChief Legal Officer | 4,398 | $3.23 | $14,206 | 305,964 | — | |
| Aug 16, 2026 FForm 4 → | Aug 17, 4:26 pm EDT | Benjamin Richard WheelerChief Financial Officer | 8,761 | $3.03 | $26,546 | 289,748 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 6:06 pm EDT | Samraat S. RahaPresident and CEO, Director | 3,542 | $3.94 | $13,941 | 1,068,083 | — | |
| Jun 11, 2026 AForm 4 → | Jun 12, 6:05 pm EDT | Brian J DonnellyChief Commerical Officer | 5,000 | $3.94 | $19,680 | 573,363 | — | |
| Jun 8, 2026 SForm 4 → | Jun 9, 4:20 pm EDT | Rashmi KumarDirector | 15,000 | $4.46 | $66,843 | 171,889 | −8.03% | 10b5-1 |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:25 pm EDT | Daniel SkovronskyDirector | 59,701 | — | — | 195,507 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:25 pm EDT | Lee Nisley NewcomerDirector | 59,701 | — | — | 191,842 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:25 pm EDT | Mark Steven DavisDirector | 59,701 | — | — | 106,665 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:25 pm EDT | S. Louise PhanstielDirector | 59,701 | — | — | 341,652 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:25 pm EDT | Heinrich DreismannDirector | 59,701 | — | — | 231,145 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:25 pm EDT | Colleen F ReitanDirector | 59,701 | — | — | 152,030 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:24 pm EDT | Paul BisaroDirector | 59,701 | — | — | 157,142 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:24 pm EDT | Rashmi KumarDirector | 59,701 | — | — | 186,889 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.